טוען...
Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases
More than 90 % of patients with metastatic castration-resistant prostate cancer (CRPC) have radiologically confirmed skeletal metastases. Traditional treatment methods such as administration of painkillers, external beam therapy, bisphosphonates or denosumab, as well as injections of strontium-89 or...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
ABV-press
2017-09-01
|
| סדרה: | Onkourologiâ |
| נושאים: | |
| גישה מקוונת: | https://oncourology.abvpress.ru/oncur/article/view/721 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|